| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |